Electra Therapeutics Inc.

Electra Therapeutics Inc.

ETRA
Electra Therapeutics Inc.US flagNASDAQ
10.37
USD
-0.31
- -
219.97MMarket Cap

Income Statement (USD)

2024 Y
2025 Y
As of date
12/31/2024
12/31/2025
Sales/Revenue/Turnover
- -
- -
+ Sales & Services Revenue
- -
- -
- Cost of Revenue
- -
- -
+ Cost of Goods & Services
- -
- -
Gross Profit
- -
- -
+ Other Operating Income
- -
- -
- Operating Expenses
26
62
+ Selling, General & Admin
7
12
+ Research & Development
19
50
+ Other Operating Expense
- -
- -
Operating Income (Loss)
-26
-62
- Non-Operating (Income) Loss
-2
- -
+ Interest Expense, Net
-2
- -
+ Interest Expense
- -
1
- Interest Income
2
1
+ Other Non-Op (Income) Loss
- -
- -
Pretax Income
-25
-62
- Income Tax Expense (Benefit)
- -
- -
- (Income) Loss from Affiliates
- -
- -
Income (Loss) from Cont Ops
-25
-62
- Net Extraordinary Losses (Gains)
- -
- -
+ Discontinued Operations
- -
- -
+ Extraord. & Accounting Changes
- -
- -
Income (Loss) Incl. MI
-25
-62
- Minority Interest
- -
- -
Net Income, GAAP
-25
-62
- Preferred Dividends
- -
- -
- Other Adjustments
- -
- -
Net Income Avail to Common, GAAP
-25
-62
EBIT
-26
-62
EBITDA
-26
-62
EBITDA Margin (%)
- -
- -
EBITA
-26
-62
Gross Margin (%)
- -
- -
Operating Margin (%)
- -
- -
Profit Margin (%)
- -
- -
Sales per Employee
- -
- -
Dividend per Share
- -
- -
Depreciation Expense
- -
- -
Basic Weighted Avg Shares
39
35
Basic EPS, GAAP
-0.63
-1.8
Basic EPS from Cont Ops
-0.63
-1.8
Diluted Weighted Avg Shares
39
35
Diluted EPS, GAAP
-0.63
-1.8
Diluted EPS from Cont Ops
-0.63
-1.8

Balance Sheet (USD)

2024 Y
2025 Y
As of date
12/31/2024
12/31/2025
Total Current Assets
19
95
+ Cash, Cash Equivalents & STI
16
87
+ Cash & Cash Equivalents
15
33
+ ST Investments
1
54
+ Accounts & Notes Receiv
- -
- -
+ Accounts Receivable, Net
- -
- -
+ Notes Receivable, Net
- -
- -
+ Loans Receivable, Net
- -
- -
+ Other Receivable, Net
- -
- -
+ Inventories
- -
- -
+ Raw Materials
- -
- -
+ Work In Process
- -
- -
+ Finished Goods
- -
- -
+ Inventory Adjustments
- -
- -
+ Other Inventory
- -
- -
+ Other ST Assets
4
9
+ Misc ST Assets
- -
- -
+ Prepaid Expenses
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
+ ST Assets Held-for-Sale
- -
- -
+ ST Deferred Tax Assets
- -
- -
Total Noncurrent Assets
- -
4
+ Property, Plant & Equip, Net
- -
3
+ Property, Plant & Equip
- -
3
- Accumulated Depreciation
- -
- -
+ LT Investments & Receivables
- -
- -
+ LT Investments
- -
- -
+ LT Receivables
- -
- -
+ Other LT Assets
- -
1
+ Total Intangible Assets
- -
- -
+ Goodwill
- -
- -
+ Other Intangible Assets
- -
- -
+ LT Deferred Tax Assets
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
+ Misc LT Assets
- -
1
Total Assets
19
99
+ Payables & Accruals
3
7
+ Accounts Payable
2
4
+ Accrued Taxes
- -
- -
+ Interest & Dividends Payable
- -
- -
+ Other Payables & Accruals
1
3
+ ST Debt
- -
1
+ ST Borrowings
- -
- -
+ ST Finance Leases
- -
1
+ Other ST Liabilities
1
2
+ Deferred Revenue
- -
- -
+ Derivatives & Hedging
- -
- -
+ Deferred Tax Liabilities
- -
- -
+ Misc ST Liabilities
1
2
Total Current Liabilities
4
10
+ LT Debt
- -
1
+ LT Borrowings
- -
- -
+ LT Finance Leases
- -
1
+ Other LT Liabilities
118
118
+ Accrued Liabilities
- -
- -
+ Pension Liabilities
- -
- -
+ Deferred Revenue
- -
- -
+ Deferred Tax Liabilities
- -
- -
+ Derivatives & Hedging
- -
- -
+ Misc LT Liabilities
118
118
Total Noncurrent Liabilities
118
120
Total Liabilities
123
130
+ Preferred Equity and Hybrid Capital
- -
133
+ Share Capital & APIC
8
10
+ Common Stock
- -
- -
+ Additional Paid in Capital
8
10
- Treasury Stock
- -
- -
+ Retained Earnings
-111
-173
+ Other Equity
- -
- -
Equity Before Minority Interest
-103
-30
+ Minority/Non Controlling Interest
- -
- -
Total Equity
-103
-30
Total Liabilities & Equity
19
99
Shares Outstanding
63
63
Number of Employees
- -
- -
Capital Leases - Total
- -
2
Net Debt
-15
-33
Net Debt to Equity
14.32
108.84
Tangible Common Equity Ratio
-531.73
-164.48
Current Ratio
4.63
9.82
Cash Conversion Cycle
- -
- -

Cash Flow Statement (USD)

2024 Y
2025 Y
As of date
12/31/2024
12/31/2025
+ Net Income
-25
-62
+ Depreciation & Amortization
- -
- -
+ Non-Cash Items
2
3
+ Stock-Based Compensation
2
2
+ Deferred Income Taxes
- -
- -
+ Asset Impairment Charge
- -
- -
+ Other Non-Cash Adj
-1
1
+ Chg in Non-Cash Work Cap
-3
-2
+ (Inc) Dec in Accts Receiv
- -
- -
+ (Inc) Dec in Inventories
- -
- -
+ (Inc) Dec in Prepaid Assets
-3
-5
+ Inc (Dec) in Accts Payable
- -
5
+ Inc (Dec) in Other
- -
-1
+ Net Cash From Disc Ops
- -
- -
Cash from Operating Activities
-26
-60
+ Change in Fixed & Intang
- -
- -
+ Disp in Fixed & Intang
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
+ Disp of Intangible Assets
- -
- -
+ Acq of Fixed & Intang
- -
-1
+ Acq of Fixed Prod Assets
- -
-1
+ Acq of Intangible Assets
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
+ Increase in Capital Stock
- -
- -
+ Decrease in Capital Stock
- -
- -
+ Net Change in LT Investment
30
-52
+ Dec in LT Investment
34
1
+ Inc in LT Investment
-5
-53
+ Net Cash From Acq & Div
- -
- -
+ Cash from Divestitures
- -
- -
+ Cash for Acq of Subs
- -
- -
+ Cash for JVs
- -
- -
+ Other Investing Activities
- -
- -
+ Net Cash From Disc Ops
- -
- -
Cash from Investing Activities
30
-53
+ Dividends Paid
- -
- -
+ Net Cash From Debt
- -
40
+ Cash From Debt
- -
40
+ Repayments of Debt
- -
- -
+ Other Financing Activities
- -
92
+ Net Cash From Disc Ops
- -
- -
Cash from Financing Activities
- -
132
Effect of Foreign Exchange Rates
- -
- -
Net Changes in Cash
4
18
EBITDA
-26
-62
EBITDA Margin (%)
- -
- -
Free Cash Flow
-26
-61
Net Cash Paid for Acquisitions
- -
- -
Free Cash Flow to Firm
- -
- -
Free Cash Flow to Equity
- -
112
Free Cash Flow per Basic Share
-0.66
-1.77
Price/Free Cash Flow
- -
- -
Cash Flow to Net Income
1.05
0.98
Capital Expenditures
- -
-1